In vivo pharmacokinetic study of antibody conjugates

The National Institutes of Health, under the Department of Health and Human Services, has issued a presolicitation notice for an in vivo pharmacokinetic study of antibody conjugates. This contract opportunity, identified by solicitation number 75N98026Q00528, is aimed at conducting detailed pharmacokinetic evaluations to better understand the behavior and efficacy of antibody conjugates within living organisms. The study is classified under the NAICS code 541380, which pertains to research and development in biotechnology. The contract is to be performed in Bethesda, Maryland, where the issuing office is also located. There is no set-aside designation applied to this solicitation, indicating that it is open to all qualified offerors. Interested parties must submit their responses by June 13, 2026, following the notice posted on June 4, 2026. For further information or to submit inquiries, the primary point of contact is David Shen, who can be reached via email. The solicitation and additional details are accessible through the SAM.gov workspace.